Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats

This study evaluated the effect of combined inositol hexakisphosphate (IP6) and inositol supplement on organ weight, intestinal ATPase activities, complete blood count, and serum analytes in streptozotocin (STZ)-induced type 2 diabetic rats. High-fat diet and a single intraperitoneal injection of st...

Full description

Saved in:
Bibliographic Details
Main Authors: Shadae R. Foster, Lowell L. Dilworth, Jean Sparks, Ruby L. Alexander-Lindo, Felix O. Omoruyi
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Advances in Pharmacological Sciences
Online Access:http://dx.doi.org/10.1155/2019/4143137
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559526798163968
author Shadae R. Foster
Lowell L. Dilworth
Jean Sparks
Ruby L. Alexander-Lindo
Felix O. Omoruyi
author_facet Shadae R. Foster
Lowell L. Dilworth
Jean Sparks
Ruby L. Alexander-Lindo
Felix O. Omoruyi
author_sort Shadae R. Foster
collection DOAJ
description This study evaluated the effect of combined inositol hexakisphosphate (IP6) and inositol supplement on organ weight, intestinal ATPase activities, complete blood count, and serum analytes in streptozotocin (STZ)-induced type 2 diabetic rats. High-fat diet and a single intraperitoneal injection of streptozotocin (35 mg/kg body weight) were used to induce type 2 diabetes mellitus in Sprague–Dawley rats. The diabetic groups were then treated with either combined IP6 and inositol supplement or glibenclamide for four weeks. Organ weights, intestinal ATPase activities, complete blood count, serum α-amylase, total protein, albumin, and globulin content were determined. Pancreatic weight was significantly reduced while relative kidney and liver weights were elevated in the group treated with combined IP6 and inositol supplement compared to the nondiabetic control. Serum α-amylase activity for the glibenclamide and combination treated groups was significantly improved compared to that of the untreated diabetic group. Red cell distribution width percentage was significantly lower in the combination treated group compared to that in the untreated diabetic group, while intestinal ATPase activities were unaffected by the treatment regime. Combined IP6 and inositol supplement consumption may protect people with diabetes from increased risk of cardiovascular diseases due to the supplement's ability to maintain red cell distribution width percentage towards the normal control group.
format Article
id doaj-art-eded95b4e30c4941a8994490349cfec0
institution Kabale University
issn 1687-6334
1687-6342
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological Sciences
spelling doaj-art-eded95b4e30c4941a8994490349cfec02025-02-03T01:29:54ZengWileyAdvances in Pharmacological Sciences1687-63341687-63422019-01-01201910.1155/2019/41431374143137Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic RatsShadae R. Foster0Lowell L. Dilworth1Jean Sparks2Ruby L. Alexander-Lindo3Felix O. Omoruyi4Department of Basic Medical Sciences, Biochemistry Section, UWI, Mona, JamaicaDepartment of Pathology, UWI, Mona, JamaicaDepartment of Life Sciences, Texas A&M University, Corpus Christi, USADepartment of Basic Medical Sciences, Biochemistry Section, UWI, Mona, JamaicaDepartment of Life Sciences, Texas A&M University, Corpus Christi, USAThis study evaluated the effect of combined inositol hexakisphosphate (IP6) and inositol supplement on organ weight, intestinal ATPase activities, complete blood count, and serum analytes in streptozotocin (STZ)-induced type 2 diabetic rats. High-fat diet and a single intraperitoneal injection of streptozotocin (35 mg/kg body weight) were used to induce type 2 diabetes mellitus in Sprague–Dawley rats. The diabetic groups were then treated with either combined IP6 and inositol supplement or glibenclamide for four weeks. Organ weights, intestinal ATPase activities, complete blood count, serum α-amylase, total protein, albumin, and globulin content were determined. Pancreatic weight was significantly reduced while relative kidney and liver weights were elevated in the group treated with combined IP6 and inositol supplement compared to the nondiabetic control. Serum α-amylase activity for the glibenclamide and combination treated groups was significantly improved compared to that of the untreated diabetic group. Red cell distribution width percentage was significantly lower in the combination treated group compared to that in the untreated diabetic group, while intestinal ATPase activities were unaffected by the treatment regime. Combined IP6 and inositol supplement consumption may protect people with diabetes from increased risk of cardiovascular diseases due to the supplement's ability to maintain red cell distribution width percentage towards the normal control group.http://dx.doi.org/10.1155/2019/4143137
spellingShingle Shadae R. Foster
Lowell L. Dilworth
Jean Sparks
Ruby L. Alexander-Lindo
Felix O. Omoruyi
Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats
Advances in Pharmacological Sciences
title Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats
title_full Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats
title_fullStr Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats
title_full_unstemmed Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats
title_short Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats
title_sort combined inositol hexakisphosphate and inositol supplement consumption improves serum alpha amylase activity and hematological parameters in streptozotocin induced type 2 diabetic rats
url http://dx.doi.org/10.1155/2019/4143137
work_keys_str_mv AT shadaerfoster combinedinositolhexakisphosphateandinositolsupplementconsumptionimprovesserumalphaamylaseactivityandhematologicalparametersinstreptozotocininducedtype2diabeticrats
AT lowellldilworth combinedinositolhexakisphosphateandinositolsupplementconsumptionimprovesserumalphaamylaseactivityandhematologicalparametersinstreptozotocininducedtype2diabeticrats
AT jeansparks combinedinositolhexakisphosphateandinositolsupplementconsumptionimprovesserumalphaamylaseactivityandhematologicalparametersinstreptozotocininducedtype2diabeticrats
AT rubylalexanderlindo combinedinositolhexakisphosphateandinositolsupplementconsumptionimprovesserumalphaamylaseactivityandhematologicalparametersinstreptozotocininducedtype2diabeticrats
AT felixoomoruyi combinedinositolhexakisphosphateandinositolsupplementconsumptionimprovesserumalphaamylaseactivityandhematologicalparametersinstreptozotocininducedtype2diabeticrats